TWST Form 144: Insider Plans Sale of 619 Shares Valued $16,071

Q: What does the TWST Form 144 disclose about the upcoming sale?

The filing discloses a proposed sale of 619 common shares valued at $16,071.84 , to be sold approximately on 08/21/2025 on NASDAQ.

Q: How were the 619 TWST shares acquired?

The shares were acquired on 08/20/2025 by restricted stock vesting and the payment nature is listed as compensation .

Q: Has the filer sold TWST shares recently?

Yes. Paula Green sold 3,174 shares across five transactions from 05/21/2025 to 08/04/2025 , generating gross proceeds of $97,059.51 .

Q: On which exchange will the TWST shares be sold?

The planned sale is to occur on NASDAQ .

Q: Does the filer claim undisclosed adverse information about Twist Bioscience?

The filer certifies by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.

[144] Twist Bioscience Corporation SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

144

Rhea-AI Filing Summary

Twist Bioscience (TWST) filed a Form 144 disclosing a proposed sale of 619 common shares with an aggregate market value of $16,071.84, to be sold approximately on 08/21/2025 on NASDAQ. The shares were acquired on 08/20/2025 upon restricted stock vesting and were issued as compensation. The filer reports prior sales by the same person, Paula Green, totaling 3,174 shares across five transactions between 05/21/2025 and 08/04/2025, producing gross proceeds of $97,059.51. The filer certifies they are unaware of any undisclosed material adverse information about the issuer.

Positive

Transparent disclosure of the proposed sale date, share count, market value, acquisition date, and nature of acquisition (restricted stock vesting).
Detailed history of prior insider sales is provided, including dates, amounts, and gross proceeds, aiding investor transparency.

Negative

Insider selling activity: the filer (Paula Green) sold 3,174 shares in the prior three months and plans to sell an additional 619 shares, which could be viewed negatively by some investors.

Insights

TL;DR: Routine insider sale following restricted stock vesting; modest size relative to typical equity floats.

This Form 144 reports a planned sale of 619 shares resulting from restricted stock vesting and notes multiple recent sales by the same insider totaling 3,174 shares and $97,059.51 in proceeds. The sale is scheduled for NASDAQ and appears to be compensation-driven rather than a cash-funded sale. For investors, this is a transparent disclosure of insider liquidity but does not, by itself, indicate material company developments.

TL;DR: Disclosure aligns with compliance expectations; repeated insider sales warrant routine monitoring.

The filing meets Rule 144 disclosure norms by identifying the source as restricted stock vesting and providing specific dates and amounts. Recurrent sales by the same individual are documented, which is useful for governance oversight and monitoring insider trading patterns. No statement in the filing indicates undisclosed adverse information, per the filer's certification.

08/21/2025 - 03:17 PM

144: Filer Information

Filer CIK

Filer CCC

Is this a LIVE or TEST Filing?

LIVE TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common

Fidelity Brokerage Services LLC
900 Salem Street
Smithfield RI 02917

619

16071.84

60360925

08/21/2025

NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common

08/20/2025

Restricted Stock Vesting

Issuer

619

08/20/2025

Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds